Sarepta Therapeutics Inc (SRPT)
128.73
+1.34
(+1.05%)
USD |
NASDAQ |
Apr 26, 16:00
128.73
0.00 (0.00%)
After-Hours: 19:40
Sarepta Therapeutics Total Return Level: 127.39 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 127.39 |
April 24, 2024 | 124.25 |
April 23, 2024 | 117.12 |
April 22, 2024 | 116.96 |
April 19, 2024 | 115.62 |
April 18, 2024 | 116.55 |
April 17, 2024 | 117.89 |
April 16, 2024 | 117.29 |
April 15, 2024 | 118.31 |
April 12, 2024 | 122.87 |
April 11, 2024 | 124.45 |
April 10, 2024 | 126.31 |
April 09, 2024 | 126.98 |
April 08, 2024 | 126.39 |
April 05, 2024 | 126.08 |
April 04, 2024 | 125.79 |
April 03, 2024 | 126.92 |
April 02, 2024 | 127.00 |
April 01, 2024 | 128.40 |
March 28, 2024 | 129.46 |
March 27, 2024 | 130.23 |
March 26, 2024 | 128.25 |
March 25, 2024 | 127.94 |
March 22, 2024 | 127.54 |
March 21, 2024 | 124.94 |
Date | Value |
---|---|
March 20, 2024 | 126.08 |
March 19, 2024 | 124.06 |
March 18, 2024 | 123.97 |
March 15, 2024 | 123.05 |
March 14, 2024 | 123.76 |
March 13, 2024 | 121.96 |
March 12, 2024 | 122.00 |
March 11, 2024 | 121.58 |
March 08, 2024 | 124.37 |
March 07, 2024 | 120.78 |
March 06, 2024 | 120.31 |
March 05, 2024 | 122.85 |
March 04, 2024 | 123.88 |
March 01, 2024 | 128.67 |
February 29, 2024 | 127.90 |
February 28, 2024 | 137.50 |
February 27, 2024 | 141.53 |
February 26, 2024 | 137.65 |
February 23, 2024 | 136.53 |
February 22, 2024 | 134.78 |
February 21, 2024 | 132.29 |
February 20, 2024 | 136.14 |
February 16, 2024 | 134.61 |
February 15, 2024 | 124.89 |
February 14, 2024 | 124.30 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
109.01
Average
111.47
Median
Aug 08 2022
Total Return Level Benchmarks
PTC Therapeutics Inc | 25.49 |
Vertex Pharmaceuticals Inc | 397.70 |
Regenxbio Inc | 16.06 |
CytomX Therapeutics Inc | 1.60 |
Apellis Pharmaceuticals Inc | 47.93 |